FOVAX | VSMAX | FOVAX / VSMAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 14 years | 24 years | - |
Gain YTD | 8.697 | 9.731 | 89% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 22.9M | 149B | 0% |
Annual Yield % from dividends | 0.00 | 1.42 | - |
Returns for 1 year | 11.79 | 20.75 | 57% |
Returns for 3 years | -16.11 | 5.70 | -283% |
Returns for 5 years | 0.26 | 51.83 | 1% |
Returns for 10 years | 12.95 | 114.09 | 11% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
NSCRX | 62.17 | 0.03 | +0.05% |
Nuveen Small-Cap Value Opps I | |||
CMGSX | 35.77 | -0.03 | -0.08% |
BlackRock Mid-Cap Growth Equity Svc | |||
FDEQX | 69.76 | -0.21 | -0.30% |
Fidelity Disciplined Equity | |||
PCITX | 22.78 | -0.07 | -0.31% |
Pioneer International Equity C | |||
PSPFX | 4.01 | -0.02 | -0.50% |
US Global Investors Global Res |